Guide Me: How Can I Prevent the Next Migraine Attack?

Qulipta Continues to Give New Hope to Migraine Warriors

Qulipta (atogepant) is FDA approved for both chronic and episodic migraine prevention in adults. Ongoing data shows safety and promising results in patients who've failed multiple other preventives.

By Wendy NeriApr 18, 2024

Why New CGRP Drugs Don’t Work for Everyone With Migraine

Migraine treatments that target a protein called calcitonin gene-related peptide (CGRP) have changed the game. Learn why these drugs don't work for everyone and what new therapies are in development.

By Lisa SmithApr 12, 2024

heads with targets to represent the therapies hitting or missing

HeadaTerm 2 Device Now FDA Cleared for Migraine Prevention

HeadaTerm 2, a newly FDA-cleared migraine prevention device, offers an affordable option for those seeking relief from frequent migraine attacks.

By Angie GlaserApr 12, 2024

Product Review: Which Are the Best Migraine Glasses?

Light sensitivity can exacerbate migraine attacks. We review some of the most popular brands of migraine glasses so you can find out which ones might be right for you.

By Natalie MeadMar 28, 2024

Sponsored Advertising Content

CGRP Monoclonal Antibodies for Migraine: A Game Changer, 5 Years In

CGRP monoclonal antibodies have been a game changer for many since they came out five years ago. Discover how these newer medications have revolutionized the treatment landscape.

By Mark Youssef, MDMar 22, 2024

Experts Recommend New CGRP-Targeted Migraine Drugs As First-Line Treatment

The American Headache Society recommends CGRP-targeting migraine drugs as first-line preventive treatments, potentially improving access for patients.

By Lisa SmithMar 15, 2024

Can Gabapentin Relieve Your Pain? What the Research Says

Discover the potential of gabapentin for preventing migraine attacks and headaches. While not a first-line treatment, it can be effective in combination with other options.

By Lauren HeathMar 1, 2024